Health care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supply

Abstract Background Armed conflict in Sudan since April 2023 has led to the widespread disruption of health care services, the destruction of public and private health care infrastructure nationwide, and the targeting of health care personnel. This study examines the impact of the conflict on a less...

Full description

Saved in:
Bibliographic Details
Main Authors: Aly Verjee, Thouiba Hashim Galad, Ruoh-Yeng Chang
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Conflict and Health
Subjects:
Online Access:https://doi.org/10.1186/s13031-025-00667-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850277616708222976
author Aly Verjee
Thouiba Hashim Galad
Ruoh-Yeng Chang
author_facet Aly Verjee
Thouiba Hashim Galad
Ruoh-Yeng Chang
author_sort Aly Verjee
collection DOAJ
description Abstract Background Armed conflict in Sudan since April 2023 has led to the widespread disruption of health care services, the destruction of public and private health care infrastructure nationwide, and the targeting of health care personnel. This study examines the impact of the conflict on a less publicized sector of Sudan’s health system: the national pharmaceutical manufacturing and supply chain. Methods Research interviews were conducted with representatives of 4 companies engaged in pharmaceutical manufacturing and/or supply in Sudan, in addition to a review of primary information from medical regulators and industry associations. Based on these interviews, 3 case studies are presented; insights from the fourth interview inform the study overall. Results All 4 companies reported significant impacts on their operations, as well as on other companies in the pharmaceutical sector. Domestic pharmaceutical manufacturing has effectively come to a halt, leading to the non-availability of certain drugs in parts of the country. Manufacturers have shifted course to focus on imports, but heavy losses of domestically stored inventory and an inability to distribute medicines to large parts of the country have had a significant impact on pharmaceutical supply to retail pharmacies, public and private sector health facilities, and the National Medical Supplies Fund (NMSF). Conclusions Sudan’s pharmaceutical manufacturing industry has been devasted. Although less visible than hospitals and medical personnel, the effects on the pharmaceutical sector are consequential for Sudan’s health sector, particularly for chronic conditions.
format Article
id doaj-art-85c8d7d82cdd4fa8afb36506780ddd57
institution OA Journals
issn 1752-1505
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series Conflict and Health
spelling doaj-art-85c8d7d82cdd4fa8afb36506780ddd572025-08-20T01:49:48ZengBMCConflict and Health1752-15052025-05-011911610.1186/s13031-025-00667-zHealth care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supplyAly Verjee0Thouiba Hashim GaladRuoh-Yeng Chang1University of GothenburgUniversity of British ColumbiaAbstract Background Armed conflict in Sudan since April 2023 has led to the widespread disruption of health care services, the destruction of public and private health care infrastructure nationwide, and the targeting of health care personnel. This study examines the impact of the conflict on a less publicized sector of Sudan’s health system: the national pharmaceutical manufacturing and supply chain. Methods Research interviews were conducted with representatives of 4 companies engaged in pharmaceutical manufacturing and/or supply in Sudan, in addition to a review of primary information from medical regulators and industry associations. Based on these interviews, 3 case studies are presented; insights from the fourth interview inform the study overall. Results All 4 companies reported significant impacts on their operations, as well as on other companies in the pharmaceutical sector. Domestic pharmaceutical manufacturing has effectively come to a halt, leading to the non-availability of certain drugs in parts of the country. Manufacturers have shifted course to focus on imports, but heavy losses of domestically stored inventory and an inability to distribute medicines to large parts of the country have had a significant impact on pharmaceutical supply to retail pharmacies, public and private sector health facilities, and the National Medical Supplies Fund (NMSF). Conclusions Sudan’s pharmaceutical manufacturing industry has been devasted. Although less visible than hospitals and medical personnel, the effects on the pharmaceutical sector are consequential for Sudan’s health sector, particularly for chronic conditions.https://doi.org/10.1186/s13031-025-00667-zSudanConflictPharmaceutical industryEssential medicines
spellingShingle Aly Verjee
Thouiba Hashim Galad
Ruoh-Yeng Chang
Health care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supply
Conflict and Health
Sudan
Conflict
Pharmaceutical industry
Essential medicines
title Health care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supply
title_full Health care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supply
title_fullStr Health care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supply
title_full_unstemmed Health care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supply
title_short Health care without medicine: the impact of war on Sudan’s pharmaceutical manufacturing and supply
title_sort health care without medicine the impact of war on sudan s pharmaceutical manufacturing and supply
topic Sudan
Conflict
Pharmaceutical industry
Essential medicines
url https://doi.org/10.1186/s13031-025-00667-z
work_keys_str_mv AT alyverjee healthcarewithoutmedicinetheimpactofwaronsudanspharmaceuticalmanufacturingandsupply
AT thouibahashimgalad healthcarewithoutmedicinetheimpactofwaronsudanspharmaceuticalmanufacturingandsupply
AT ruohyengchang healthcarewithoutmedicinetheimpactofwaronsudanspharmaceuticalmanufacturingandsupply